Contact this trialFirst, we need to learn more about you.
Procedure
HU6 for Type 2 Diabetes with Risk of Fatty Liver Disease
Recruiting0 awardsPhase 2
Marrero, Louisiana
This trial tests an experimental drug to treat obese people with type 2 diabetes and risk of NASH. Six months of dosing will be monitored for safety, efficacy, and more.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.